HEARTLINE HSM Genoa Cardiology Meeting - Aristea

More documents

Recommendations

Info

6 Bibliograa 1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 2 randomised trials. Lancet. 200 ; 61(9 1):1 -20. 2. Van de Werf F, Ardissino D, Betriu A, et al, for the Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST segment elevation. Eur Heart J 200 ; 2 : 28-66 . Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck- Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909- . . Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC, Jr., Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 Focused Update of the ACC/AHA 200 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 200 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 200 Writing Committee. Circulation 2008;117:296- 29. . G. Guagliumi. Regional Differencies in the approach to STEMI. Londra 1 jul 2011 http://www.ambitalia.org.uk/Infarction/ Myocardial_Infarction_Programme_Final_1.pdf 6. GISE-Società Italiana di Cardiologia Invasiva. Attività dei laboratori. http://www.gise.it/il_gise/122/attivita_dei_laboratori# (visited 0 sept 2011) 7. Olivari Z.L’esperienza del Blitz qualità.Firenze 1 maggio 2011,Congresso nazionaleANMCO.http://www.anmco.it/olivari_1 _ _11.pdf 8. Krumholz HM, Herrin J, Miller LE, Drye EE, Ling SM, Han LF, Rapp MT, Bradley EH, Nallamothu BK, Nsa W, Bratzler DW, Curtis JP. Improvements in Door-to-Balloon Time in the United States, 200 to 2010. Circulation. 2011 Aug 0;12 (9):10 8- . Epub 2011 Aug 22. 9. Rosato S. “Indicatori di esito nell’area cardiovascolare: l’esempio della Mortalità a 0 giorni dopo ricovero per Infarto Miocardico Acuto” Roma, EUR, Palazzo Congressi. 16 giugno 2011 “La salute degli italiani nei dati del CNESPS.” http://www.epicentro.iss.it/temi/politiche_sanitarie/pdf/cnesps2011/Rosato.pdf 10.Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non- ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation 2006;11 :7 2-761 11.McNamara RL, Wang Y, Herrin J, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006; 7:2180-2186 12.Brodie BR, Hansen C, Stuckey TD, et al. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol 2006; 7:289–29 . 1 .Nallamothu BK, Bradley EH, Krumholz HN, et al. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007; 7:16 1-16 8. 1 .Bassand JP, Danchin N, Filippatos G, et al. Implementation of reperfusion therapy in acute myocardial infarction. Proceedings from the policy conference on implementation of reperfusion therapy in acute myocardial infarction. Eur Heart J 200 ;26:27 –27 1. 1 .Antoniucci D, Valenti R, Migliorini A, et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 2002;89:12 8-12 2. 16.Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST- elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006;11 (19):2019-202 . 17.Ortolani P, Marzocchi A, Marrozzini C, et al. Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. Eur Heart J 2006;27:1 0–1 7. 18.De Luca G, Suryapranata H, Zijlstra F, et al. Symptom onset to balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 200 ; 2:991–997 19.D2B: An Alliance for Quality, home page. http://www.d2balliance.org 20.Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, Alessi L, Nardini P, Bacchi Reggiani ML, Guastaroba P, De Palma R, Grilli R, Picoco C, Gordini G, Branzi A. Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benets. EuroIntervention. 2011 Aug;7( ): 9- 7. 21.Pavesi PC, Nobilio L, De Palma R, Casella G, Di Pasquale G, Grilli R. [The evolution of intensive cardiac care units and the effects of interhospital networks for reperfusion implementation. Analysis of the Emilia-Romagna regional data, 2002 to 2007].G Ital Cardiol (Rome). 2011 Jan;12(1): 1- 2. 22.Oltrona L, Mafrici A, Marzegalli M, Fiorentini C, Pirola R, Vincenti A; Studio GestIMA e della Sezione Regionale Lombarda dell'ANMCO e della SIC. [The early management of ST-elevation acute myocardial infarction in the Lombardy Region (GestIMA)]. Ital Heart J Suppl. 200 Aug;6(8): 89-97.
2 .Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, Schreiber W, Unger G, Glogar HD, Kaff A, Laggner AN, Maurer G, Mlczoch J, Slany J, Weber HS, Huber K; Vienna STEMI Registry Group. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation. 2006 May 2 ;11 (20):2 98- 0 . Epub 2006 May 1 . 2 .Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, Davies RF, Sherrard HL, Maloney J, Marquis JF, O’Brien ER, Trickett J, Poirier P, Ryan SC, Ha A, Joseph PG, Labinaz M. A city- wide protocol for primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2008; 8:2 1- 0. 2 .Galvani M. Highlight, Sindromi coronariche acute. Congresso nazionale ANMCO. Firenze 1 maggio 2011. ANMCO - Highlight Congresso 2011 26.Genova oggi, Genova domani; Loggia di Banchi, 1 luglio 2011. http://www.urbancenter.comune.genova.it/node/909 27.Di Pasquale G. “MANTRA” Management of patients with ACS in the real world practice in Italy: an outcomes research study focused on the use of ANTithRombotic Agents. Congresso nazionale ANMCO. Firenze 1 maggio 2011. Anmco - Associazione Nazionale Medici Cardiologi 6
Page 1:
HEARTLINE BOOK HEARTLINE HSM Genoa
Page 5 and 6:
Infarto Miocardico Acuto Esteso: c
Page 7 and 8:
La siopatologia cellulare dell’in
Page 9 and 10:
Sia in modelli di piccola che di gr
Page 11 and 12:
Citochine nell’infarto miocardico
Page 13 and 14: mande ci viene probabilmente sugger
Page 15 and 16: L’ecocontrastograa nello studio d
Page 17 and 18: imaging molecolare con ECM, permett
Page 19 and 20: mostrato che il miocardio ischemico
Page 21 and 22: Trial Clinici sulla Terapia Cellula
Page 23 and 24: nistra dopo riperfusione efcace. I
Page 25 and 26: “Apical Ballooning Syndrome”: c
Page 27 and 28: Fig. 3 ABS: ECG di presentazione in
Page 29 and 30: Lesioni Coronariche critiche in sin
Page 31 and 32: Infarto Miocardico Acuto: nuovi ori
Page 33 and 34: (1.9%), indipendentemente dal tratt
Page 35 and 36: I dati clinici a tre anni del Trial
Page 37 and 38: Cardiopatia Ischemica: nuovi orizzo
Page 39 and 40: Prasugrel Anche il Prasugrel è un
Page 41 and 42: Montalescot G, Wiviott SD, Braunwal
Page 43 and 44: che riunisce tutti gli ospedali con
Page 45 and 46: Costituzione di reti per lo shock c
Page 47 and 48: • Hub vs OspRER: due ricoveri, am
Page 49 and 50: Discussione Lo studio ha analizzato
Page 51: Nella TERZA FASE • Il progetto e
Page 54 and 55: Infarto miocardico acuto con ST sop
Page 56 and 57: 6 Nel registro STEMI del San Martin
Page 58 and 59: 8 Un terzo dei pz. proveniva dal 11
Page 60 and 61: 60 Outcome in base al rischio ed al
Page 62 and 63: 62 più rapidi rispetto a quelli ch
Page 66 and 67: 66 Infarto miocardico acuto con ST
Page 68 and 69: 68 Tabella 1 Tabella 2 Caratteristi
Page 70 and 71: 70 tanto è stato eliminato dal pro
Page 72 and 73: 72 Pazienti con STEMI suddivisi per
Page 74 and 75: 7 Flusso TIMI al termine della proc
Page 76 and 77: 76 Poche riessioni. I cittadini che
Page 78 and 79: 78 A tutt'oggi la diagnosi e la cur
Page 80 and 81: 80 Laboratorio di emodinamica • E
Page 82 and 83: 82 centro dove angiograa e PCI poss
Page 84 and 85: 8 (aneurisma del ventricolo sinistr
Page 86 and 87: 86 coci e con ampia area a rischio,
Page 88 and 89: 88 brinolisi e poi trasferiti per e
Page 90 and 91: 90 h. Reinfarto in sede elettrocard
Page 92 and 93: 92 Raccolta dati Dati da Raccoglier
Page 94 and 95: 9 -Stone GW, Witzenbichler B, Guagl
Page 96 and 97: 96 Tabella 2 Confronto modalità di
Page 98 and 99: 98 Le ragioni di questo fenomeno no
Page 100 and 101: 100 (“gMPS"), che consiste di mul
Page 102 and 103: 102 Figura 2 Tabella 1 Tabella 2 Da
Page 104 and 105: 10 Tabella 4 Tabella 5 che 6/12 ( 7
Page 106 and 107: 106 Tabella 8 Tabella 9 Le complica
Page 108 and 109: 108 Tabella 11 B Tabella 11 C Nella
Page 110 and 111: 110 Monitoraggio in remoto dei pazi
Page 112 and 113: 112 Percutaneous LAA Closure for St
Page 114 and 115:
11 Primary Safety Endpoint included
Page 116 and 117:
116 Fibrillazione Atriale: nuovi sc
Page 118 and 119:
118 Inibitori diretti del fattore X
Page 121 and 122:
Conclusioni Sulla base degli studi
Page 123 and 124:
Negli anni, il numero degli interve
Page 125 and 126:
Via di accesso TS Centro PRE INT FI
Page 127 and 128:
TF-AVI o TAVI in approccio transasc
Page 129 and 130:
Gestione postoperatoria dei pazient
Page 131 and 132:
• 1 insufcienza aortica paraprote
Page 133 and 134:
Allegato 1 Modulo di presentazione
Page 135:
Difetto del setto interventricolare
Page 138 and 139:
1 8 Indice pag. Infarto Miocardico
show all

HEARTLINE HSM Genoa Cardiology Meeting - Aristea

Create successful ePaper yourself

Delete template?

Save as template?